Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk

• Cheng-Hsien Hung,
• Chun-Ting Lin,
• James Cheng-Chung Wei

Affiliations

Cheng-Hsien Hung

Department of Pharmacy, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

Chun-Ting Lin

Department of pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

James Cheng-Chung Wei

Correspondence to: No.110, Section1, Jianguo N.Rd., South Dist., Taichung 402, Taiwan.; Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan 030032, China; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Institute of Medicine/Department of Nursing, Chung Shan Medical University, Taichung, Taiwan